Zhejiang Tailin Bioengineering Co Ltd (300813) — Net Asset Quality Index
Zhejiang Tailin Bioengineering Co Ltd (300813) has a Net Asset Quality Index of 85.2% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥946.91 Million minus total liabilities of CN¥140.46 Million yields net assets of CN¥806.45 Million. A higher index indicates a stronger, lower-leverage balance sheet. See Zhejiang Tailin Bioengineering Co Ltd defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Zhejiang Tailin Bioengineering Co Ltd Net Asset Quality Index Over Time (2013–2025)
This chart shows how Zhejiang Tailin Bioengineering Co Ltd's Net Asset Quality Index has evolved across 13 annual periods from 2013 to 2025. As of March 2026, the index stands at 85.2%, representing net assets of CN¥806.45 Million against total assets of CN¥946.91 Million CNY. Explore cash efficiency ratio of Zhejiang Tailin Bioengineering Co Ltd to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Zhejiang Tailin Bioengineering Co Ltd (2013–2025)
The table below presents the year-by-year Net Asset Quality Index for Zhejiang Tailin Bioengineering Co Ltd from 2013 to 2025, covering 13 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see 300813 stock market capitalisation.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 83.8% | CN¥804.29 Million | CN¥959.34 Million | CN¥155.04 Million | ▼ -1.7 pp |
| 2024 | 85.5% | CN¥820.73 Million | CN¥959.91 Million | CN¥139.18 Million | ▲ +18.7 pp |
| 2023 | 66.8% | CN¥650.24 Million | CN¥973.51 Million | CN¥323.27 Million | ▼ -3.4 pp |
| 2022 | 70.2% | CN¥647.45 Million | CN¥922.66 Million | CN¥275.21 Million | ▼ -5.7 pp |
| 2021 | 75.8% | CN¥497.38 Million | CN¥655.87 Million | CN¥158.49 Million | ▼ -6.4 pp |
| 2020 | 82.3% | CN¥444.24 Million | CN¥539.99 Million | CN¥95.75 Million | ▼ -3.6 pp |
| 2019 | 85.8% | CN¥229.11 Million | CN¥266.91 Million | CN¥37.81 Million | ▲ +9.5 pp |
| 2018 | 76.3% | CN¥194.70 Million | CN¥255.12 Million | CN¥60.42 Million | ▲ +0.6 pp |
| 2017 | 75.7% | CN¥146.48 Million | CN¥193.59 Million | CN¥47.10 Million | ▲ +1.1 pp |
| 2016 | 74.6% | CN¥116.31 Million | CN¥155.97 Million | CN¥39.66 Million | ▲ +0.3 pp |
| 2015 | 74.2% | CN¥97.42 Million | CN¥131.22 Million | CN¥33.79 Million | ▲ +4.0 pp |
| 2014 | 70.2% | CN¥55.04 Million | CN¥78.39 Million | CN¥23.35 Million | ▼ -9.0 pp |
| 2013 | 79.2% | CN¥64.92 Million | CN¥81.97 Million | CN¥17.06 Million | — |